Drugs: Finance:Written question - 83

(Bristol East)

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 27 May 2015
Department of Health
Drugs: Finance
To ask the Secretary of State for Health, what assessment he has made of the implications for his Department's policies of plans in Scotland to double the New Medicines Fund; and what his policy is on creating such a fund in England.
Answered by: George Freeman
Answered on: 01 June 2015

It is a matter for the Scottish Government to decide how to use the apportioned payments they receive from the Pharmaceutical Price Regulation Scheme (PPRS).

The Government has no plans to create a New Medicines Fund in England.

The Government established the Cancer Drugs Fund to ensure that cancer patients in England have better access to life-extending and improving drugs not routinely funded by the National Health Service. Between October 2010 and December 2014 the Fund has helped over 67,000 cancer patients.

The Government is implementing all of the commitments in the PPRS on improving access to innovative medicines commensurate with the outcomes they offer patients. In addition, NHS England and the Association of the British Pharmaceutical Industry are pressing ahead with plans to maximise the benefits of the PPRS by improving access to and optimising the use of medicines to improve patient outcomes.

In addition the Accelerated Access Review is looking at a range of proposals for accelerating access to innovative medicines to NHS patients and the potential for securing more value from the NHS research infrastructure in commissioning innovative medicines.

Share this page